$GCTK
GlucoTrack Inc Stock $gctk

$gctk Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-Q Financial Statement

#000117891315003458 Filed on November 16, 2015

Income Statement

Concept	2015 Q4	2015 Q3	2014 Q4
Revenue	$0.00		$30.00K
YoY Change	-100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$880.0K	$563.3K	$520.0K
YoY Change	69.23%	29.11%	108.0%
% of Gross Profit
Research & Development	$670.0K	$560.2K	$520.0K
YoY Change	28.85%	32.84%	-1.89%
% of Gross Profit
Depreciation & Amortization	$10.00K	$10.00K	$0.00
YoY Change		0.0%	-100.0%
% of Gross Profit
Operating Expenses	$1.550M	$1.123M	$1.040M
YoY Change	49.04%	30.94%	33.33%
Operating Profit		-$1.123M
YoY Change		35.25%
Interest Expense	$10.00K	$30.00K	$30.00K
YoY Change	-66.67%	-50.0%	-100.47%
% of Operating Profit
Other Income/Expense, Net			$210.0K
YoY Change
Pretax Income	-$1.540M	-$1.100M	-$780.0K
YoY Change	97.44%	42.86%	-89.14%
Income Tax
% Of Pretax Income
Net Earnings	-$1.670M	-$1.096M	$5.110M
YoY Change	-132.68%	42.41%	-167.68%
Net Earnings / Revenue			17033.33%
Basic Earnings Per Share
Diluted Earnings Per Share	-$3.88	-$2.83	$12.46
COMMON SHARES
Basic Shares Outstanding	5.549M shares	5.513M shares	5.307M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2015 Q4	2015 Q3	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$610.0K	$2.100M	$5.830M
YoY Change	-89.54%	-52.16%	143.93%
Cash & Equivalents	$610.0K	$2.105M	$5.828M
Short-Term Investments
Other Short-Term Assets	$270.0K	$247.1K	$113.8K
YoY Change	137.17%	139.77%	22.34%
Inventory	$820.0K	$260.3K	$83.65K
Prepaid Expenses			$46.09K
Receivables	$20.00K	$21.20K	$23.25K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.710M	$2.633M	$6.048M
YoY Change	-71.73%	-43.24%	143.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$220.0K	$185.8K	$122.5K
YoY Change	79.61%	48.17%	14.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$200.0K	$200.0K	$180.0K
YoY Change	11.11%	5.26%	5.88%
Total Long-Term Assets	$420.0K	$385.5K	$300.0K
YoY Change	40.02%	23.47%	8.19%
TOTAL ASSETS
Total Short-Term Assets	$1.710M	$2.633M	$6.048M
Total Long-Term Assets	$420.0K	$385.5K	$300.0K
Total Assets	$2.130M	$3.019M	$6.348M
YoY Change	-66.45%	-39.03%	130.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.080M	$465.1K	$104.7K
YoY Change	931.41%	139.33%	110.32%
Accrued Expenses			$235.9K
YoY Change			434.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00		$450.0K
YoY Change	-100.0%
Total Short-Term Liabilities	$1.510M	$834.5K	$1.000M
YoY Change	51.0%	44.73%	221.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$660.0K	$720.0K	$2.430M
YoY Change	-72.84%	-73.43%	-73.44%
Total Long-Term Liabilities	$660.0K	$721.1K	$2.432M
YoY Change	-72.86%	-73.34%	-73.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.510M	$834.5K	$1.000M
Total Long-Term Liabilities	$660.0K	$721.1K	$2.432M
Total Liabilities	$2.170M	$1.556M	$3.432M
YoY Change	-36.77%	-52.6%	-63.71%
SHAREHOLDERS EQUITY
Retained Earnings		-$27.71M	-$23.09M
YoY Change		24.91%	-10.0%
Common Stock		$21.98M	$18.19M
YoY Change		27.76%	25.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$30.00K	-$5.652M	-$4.832M
YoY Change
Total Liabilities & Shareholders Equity	$2.130M	$3.019M	$6.348M
YoY Change	-66.45%	-39.03%	130.33%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2014 Q4
OPERATING ACTIVITIES
Net Income	-$1.670M	-$1.096M	$5.110M
YoY Change	-132.68%	42.41%	-167.68%
Depreciation, Depletion And Amortization	$10.00K	$10.00K	$0.00
YoY Change		0.0%	-100.0%
Cash From Operating Activities	-$1.460M	-$1.270M	-$940.0K
YoY Change	55.32%	47.67%	0.0%
INVESTING ACTIVITIES
Capital Expenditures	$50.00K	$70.00K	$10.00K
YoY Change	400.0%		0.0%
Acquisitions
YoY Change
Other Investing Activities	-$40.00K	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$80.00K	-$80.00K	-$10.00K
YoY Change	700.0%	166.67%	0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	30.00K	0.000	2.430M
YoY Change	-98.77%	-100.0%	-1450.0%
NET CHANGE
Cash From Operating Activities	-1.460M	-1.270M	-940.0K
Cash From Investing Activities	-80.00K	-80.00K	-10.00K
Cash From Financing Activities	30.00K	0.000	2.430M
Net Change In Cash	-1.510M	-1.350M	1.480M
YoY Change	-202.03%	-135.16%	-230.97%
FREE CASH FLOW
Cash From Operating Activities	-$1.460M	-$1.270M	-$940.0K
Capital Expenditures	$50.00K	$70.00K	$10.00K
Free Cash Flow	-$1.510M	-$1.340M	-$950.0K
YoY Change	58.95%	55.81%	0.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	igap	Gain Loss On Unit Conversion GainLossOnUnitConversion		USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8243	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	6344340	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3724	USD
	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	666	USD
	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	-1384	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-23877	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	119148	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9227	USD
CY2015Q3	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	-27511	USD
CY2015Q3	igap	Gain Loss On Unit Conversion GainLossOnUnitConversion	-13383	USD
	dei	Document Type DocumentType	10-Q
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	Integrity Applications, Inc.
	dei	Document Period End Date DocumentPeriodEndDate	2015-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	dei	Entity Central Index Key EntityCentralIndexKey	0001506983
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2770503	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	-701171	USD
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted		USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4619975	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	83653	USD
CY2014Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11637	USD
CY2014Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	16459	USD
CY2014Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	55557	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-868072	USD
CY2015Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted		USD
CY2015Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-849	USD
CY2015Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	14392	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-68374	USD
CY2015Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	27839	USD
CY2014Q3	igap	Gain Loss On Unit Conversion GainLossOnUnitConversion		USD
CY2014Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		USD
CY2014Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	50635	USD
CY2014Q3	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	2024	USD
CY2014Q3	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	-61120	USD
CY2014Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	12509	USD
CY2014Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted		USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1185807	USD
CY2015Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	182492	USD
CY2015Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	46802	USD
CY2015Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	30975	USD
CY2015Q3	us-gaap	Inventory Net InventoryNet	260269	USD
	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	-6355641	USD
CY2015Q3	igap	Linkage Difference On Principal Of Loans From Stockholders LinkageDifferenceOnPrincipalOfLoansFromStockholders	488	USD
	igap	Gain Loss On Unit Conversion GainLossOnUnitConversion	-1284354	USD
	igap	Financing Income Expenses Net FinancingIncomeExpensesNet	1196926	USD
	us-gaap	Proceeds From Repurchase Of Redeemable Preferred Stock ProceedsFromRepurchaseOfRedeemablePreferredStock	7300000	USD
CY2013	us-gaap	Proceeds From Repurchase Of Redeemable Preferred Stock ProceedsFromRepurchaseOfRedeemablePreferredStock	5300000	USD
CY2012	igap	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	1000000	USD
CY2015Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27707038	USD
CY2015Q3	us-gaap	Stockholders Equity StockholdersEquity	-5652403	USD
CY2014Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-741680	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2385911	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4387980	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2104858	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2002069	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-40970	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4542421	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	277852	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-79543	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	51485	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2419839	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	140541	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	151892	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	16354	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	139308	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14319	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-6344340	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	19854	USD
	us-gaap	Depreciation Depreciation	26091	USD
	us-gaap	Net Income Loss NetIncomeLoss	3755438	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4297307	USD
	us-gaap	Depreciation Depreciation	29709	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15675	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-119148	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1251	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	180144	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	135485	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	363639	USD
CY2015Q3	us-gaap	Other Assets Current OtherAssetsCurrent	247124	USD
CY2015Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21197	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3107214	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94714	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-118993	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	52361	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-439939	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-492300	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-4195	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-3722702	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock		USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	2384429	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	2435844	USD
	igap	Increase Decrease In Funds In Respect Of Employee Rights Upon Retirement IncreaseDecreaseInFundsInRespectOfEmployeeRightsUponRetirement	-28058	USD
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		USD
CY2015Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7115716	USD
CY2015Q3	us-gaap	Common Stock Value CommonStockValue	5550	USD
CY2015Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	21972776	USD
CY2015Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	76309	USD
CY2015Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3018913	USD
CY2015Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q3	us-gaap	Assets Current AssetsCurrent	2633448	USD
CY2015Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	185796	USD
CY2015Q3	igap	Funds In Respect Of Employee Rights Upon Retirement Noncurrent FundsInRespectOfEmployeeRightsUponRetirementNoncurrent	199669	USD
CY2015Q3	us-gaap	Assets Assets	3018913	USD
CY2015Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	465084	USD
CY2015Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	369422	USD
CY2015Q3	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent		USD
CY2015Q3	us-gaap	Liabilities Current LiabilitiesCurrent	834506	USD
CY2015Q3	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	160581	USD
CY2015Q3	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	208874	USD
CY2015Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	351639	USD
CY2015Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	721094	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6348266	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	-4832203	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23087063	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	66670	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	18182866	USD
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	5324	USD
CY2014Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7748685	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2431777	USD
CY2014Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	2057618	USD
CY2014Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	210700	USD
CY2014Q4	us-gaap	Due To Officers Or Stockholders Noncurrent DueToOfficersOrStockholdersNoncurrent	163459	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1000007	USD
CY2014Q4	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	454532	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	440764	USD
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	104711	USD
CY2014Q4	us-gaap	Assets Assets	6348266	USD
CY2014Q4	igap	Funds In Respect Of Employee Rights Upon Retirement Noncurrent FundsInRespectOfEmployeeRightsUponRetirementNoncurrent	177470	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122491	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	6048305	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	113842	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23250	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5827560	USD
CY2015Q3	us-gaap	Liabilities Liabilities	1555600	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3431784	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1123481	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	1123481	USD
CY2015Q3	us-gaap	Revenues Revenues		USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	560189	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	563292	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3767296	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	11858	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2600203	USD
	us-gaap	Costs And Expenses CostsAndExpenses	2627512	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1299935	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1327577	USD
	us-gaap	Revenues Revenues	27309	USD
	us-gaap	Revenues Revenues	143167	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1596494	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1647054	USD
	us-gaap	Costs And Expenses CostsAndExpenses	3243548	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3100381	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9639	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4287668	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-1095970	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-46081	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1142051	USD
CY2014Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	27891	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-769571	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	436296	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	421704	USD
CY2014Q3	us-gaap	Revenues Revenues	27309	USD
CY2014Q3	us-gaap	Costs And Expenses CostsAndExpenses	858000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-830691	USD
	us-gaap	Dividends Stock DividendsStock		USD
	igap	Stock Issued During Period Value Conversion Of Convertible Preferred Stock StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStock	58817	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9639	USD
	igap	Adjustments To Additional Paid In Capital Investor Warrant Issued AdjustmentsToAdditionalPaidInCapitalInvestorWarrantIssued	3445337	USD
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend		USD
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	52361	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15675	USD
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.85
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.85
CY2015Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	igap	Number Of Units Sold NumberOfUnitsSold	8500	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5513265	shares
CY2015Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9539832	shares
CY2014Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4160346	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5323058	shares
CY2015Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2015Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5549452	shares
CY2015Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5549452	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5304100	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5323058	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5303721	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5426688	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5426688	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9425407	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3574815	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5352039	shares
CY2013Q1	igap	Number Of Units Sold NumberOfUnitsSold	6300	shares
CY2015Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5549452	shares

Files In Submission

Name	View Source	Status
0001178913-15-003458-index-headers.html	Edgar Link	pending
0001178913-15-003458-index.html	Edgar Link	pending
0001178913-15-003458.txt	Edgar Link	pending
0001178913-15-003458-xbrl.zip	Edgar Link	pending
exhibit_31-1.htm	Edgar Link	pending
exhibit_31-2.htm	Edgar Link	pending
exhibit_32-1.htm	Edgar Link	pending
exhibit_32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
igap-20150930.xml	Edgar Link	completed
igap-20150930.xsd	Edgar Link	pending
igap-20150930_cal.xml	Edgar Link	unprocessable
igap-20150930_def.xml	Edgar Link	unprocessable
igap-20150930_lab.xml	Edgar Link	unprocessable
igap-20150930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk1517583.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GCTK
GlucoTrack Inc Stock $gctk

2015 Q4 Form 10-Q Financial Statement

#000117891315003458 Filed on November 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GCTK GlucoTrack Inc Stock $gctk

2015 Q4 Form 10-Q Financial Statement

#000117891315003458 Filed on November 16, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GCTK
GlucoTrack Inc Stock $gctk